These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11180198

  • 1. Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in rats.
    Hurh E, Lee E, Lee A, Kim Y, Kim S, Kim S, Lee M.
    Biopharm Drug Dispos; 2000 Jul; 21(5):193-204. PubMed ID: 11180198
    [Abstract] [Full Text] [Related]

  • 2. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
    Hurh E, Lee EJ, Kim YG, Kim SY, Kim SH, Kim YC, Lee MG.
    Res Commun Mol Pathol Pharmacol; 2000 Jul; 108(3-4):261-73. PubMed ID: 11913717
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of physostigmine on the pharmacokinetics of intravenous parathion in rats.
    Hurh E, Lee EJ, Kim YG, Kim SY, Kim SH, Kim YC, Lee MG.
    Biopharm Drug Dispos; 2000 Nov; 21(8):331-8. PubMed ID: 11514953
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats.
    Bae SK, Lee SJ, Kim YH, Kim T, Lee MG.
    J Pharm Pharmacol; 2005 Apr; 57(4):443-52. PubMed ID: 15831204
    [Abstract] [Full Text] [Related]

  • 7. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats.
    Lee DY, Lee SJ, Lee MG.
    Int J Pharm; 2005 Jul 14; 298(1):38-46. PubMed ID: 15890479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes.
    Amacher DE, Schomaker SJ.
    Toxicol Lett; 1998 Jan 31; 94(2):115-25. PubMed ID: 9574808
    [Abstract] [Full Text] [Related]

  • 13. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
    Choi YH, Lee MG.
    Br J Pharmacol; 2006 Oct 31; 149(4):424-30. PubMed ID: 16940989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
    Menicagli S, Lippi A, Criscuoli M, Gervasi PG.
    Biochem Pharmacol; 1993 Mar 09; 45(5):1097-105. PubMed ID: 8461039
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of cytochrome P450 3A1/2 as the major P450 isoform responsible for the metabolism of fentanyl by rat liver microsomes.
    Feierman DE.
    Anesth Analg; 1996 May 09; 82(5):936-41. PubMed ID: 8610902
    [Abstract] [Full Text] [Related]

  • 20. Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes.
    Roos PH, Mahnke A.
    Biochem Pharmacol; 1996 Jul 12; 52(1):73-84. PubMed ID: 8678911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.